Stay updated on Comparing Antiviral Drugs in COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Comparing Antiviral Drugs in COVID-19 Clinical Trial page.

Latest updates to the Comparing Antiviral Drugs in COVID-19 Clinical Trial page
- Check2 days agoChange DetectedThe NOR Solidarity COVID-19 trial record is displayed with its study design, antiviral treatment arms, outcome measures, eligibility criteria, and administrative details.SummaryDifference55%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0. The study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide NIH notice announces updates and explains that both “Artificial Intelligence” and “Super Intelligence” terminology may appear during a transition.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe error page’s revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now renders a 403 Forbidden error, replacing the usual study record content with a standard error page. The additions show the 403 header and HTML, and the rest of the study content and metadata is removed.SummaryDifference19%

Stay in the know with updates to Comparing Antiviral Drugs in COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Antiviral Drugs in COVID-19 Clinical Trial page.